Bioinvent International AB (PK) (BOVNF)
USOTC
News
Market Data
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current BOVNF market cap is 216.4M. The company's latest EPS is SEK -6.5250 and P/E is -0.50.
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Revenue | 147.37M | 19.38M | 326.13M | 71.46M | 44.69M |
| Operating Income | -74.96M | -278.17M | -50.47M | -370.56M | -471.25M |
| Net Income | -76.33M | -278.44M | -42.5M | -330.3M | -429.38M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Assets | 802.64M | 1.45B | 1.71B | 1.4B | 989.24M |
| Total Liabilities | 59.14M | 80.32M | 106.09M | 90.45M | 103.42M |
| Total Equity | 743.5M | 1.37B | 1.61B | 1.31B | 885.82M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Operating | -62.62M | -245.84M | -41.23M | -341.69M | -380.47M |
| Investing | -6.7M | -467.54M | -628.85M | 59.68M | 564.35M |
| Financing | 644.62M | 894.87M | 273.49M | 23.14M | -8.46M |
| Market Cap | 216.4M |
| Price to Earnings Ratio | -0.50 |
| Price to Sales Ratio | 4.84 |
| Price to Cash Ratio | 0.5 |
| Price to Book Ratio | 0.24 |
| Dividend Yield | - |
| Shares Outstanding | 65.8M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 463.35k |
| 52 Week Change | -30.03% |
| 52 Week High | 4.70 |
| 52 Week Low | 3.2886 |
| Spread (Intraday) | 503.76 (100%) |
| Company Name | Bioinvent International AB (PK) |
| Address |
the gamma building lund SE-223 70 |
| Website | https://www.bioinvent.com |
| Industry | drugs-health r&d/testing labs (H8) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
